Given the established role of PKC isoforms in renal diseases—particularly in modulating oxidative and inflammatory responses [63,64]—we propose that PKC activation, mediated by both phorbol esters and oxidative stress, may contribute to the renal dysfunction observed in our study [65]. Here, PRRT2 is linked to kidney disorder.